Regeneron's Schleifer: American public companies should fund 'infrastructure bank'; Sherlock closes $49M round for CRISPR diagnostic work
→ The candid chief of Regeneron Pharmaceuticals $REGN Leonard Schleifer made a provocative suggestion to remedy the burgeoning US infrastructure crisis, citing research that emphasizes the issue is not just financial, but indeed a public health and safety hazard. For the next three years, he asserted in an NYT op-ed on Tuesday, “every American public company [should] be required to issue 1 percent of its equity in the form of new stock to a newly formed infrastructure ‘bank.’ Given that American public companies have a collective market capitalization of about $30 trillion, this would raise about $1 trillion in three years.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
